Webinars

A Closer Look at Skin Cancer Webinars

Join us for an expert-led webinar series that delves into key aspects of the skin cancer care journey. Hosted by Krista M. Rubin, RN, MS, FNP-BC, and featuring leaders in dermatology and oncology, A Closer Look at Skin Cancer offers insightful discussions on a range of topics. From treatment options and side effect management to emotional well-being, clinical trials, and personalized medicine, this series provides a comprehensive guide to advancements in skin cancer care.

Each session provides comprehensive, real-world insights to help you better understand the complexities of skin cancer and navigate care with confidence.

2025–2026 Webinars

Skin Cancer in Aging Veterans: Unique Risks & Considerations
Date: October 29, 2025
A focused discussion on the unique risks and considerations for aging veterans living with skin cancer with our guest Dr. Rebecca Hartman, MD, MPH, Assistant Professor at Harvard Medical School and Chief of Dermatology at VA Boston Healthcare System. <Watch>

The Rising Toll: Understanding the Surge in Skin Cancer Mortality
Date: Wednesday, January 28, 2026
Time: 7:00 – 7:30 PM EST / 6:00 – 6:30 PM CST / 5:00 – 5:30 PM MST / 4:00 – 4:30 PM PST

Description:
Join Dr. Wesley Yu, double board-certified in Dermatology and Mohs micrographic surgery, for a 30-minute webinar hosted by Krista M. Rubin, RN, MS, FNP-BC. Dr. Yu specializes in treating skin cancers—including basal cell carcinoma, squamous cell carcinoma, and melanoma—using Mohs surgery for the highest cure rates and best cosmetic outcomes.

In this session, he will discuss rising skin cancer rates, key risk factors—including sun exposure in winter and sunny climates—and practical strategies for prevention and early detection. A Q&A session will follow, giving you actionable steps to protect yourself and your loved ones.

This webinar will explore recent trends in skin cancer mortality and emphasize prevention strategies, including sun safety during winter months and for those who spend time in sunnier climates.

Advancing Care: Current Clinical Trials in Cutaneous SCC
Date: TBD March 2026
An overview of current clinical trials for cutaneous squamous cell carcinoma and opportunities for patient participation.

When Skin Cancer Returns: Best Practices in Recurrence Management
Date: TBD June 2026
Expert guidance on monitoring, treatment, and management strategies for patients experiencing skin cancer recurrence.


About Our Host: Krista Rubin MS, FNP-BC

Krista M. Rubin, RN, MS, FNP-BC, Chair of the Melanoma Nursing Initiative (MNI), a nurse practitioner in the Center for Melanoma at Massachusetts General Hospital, and AIM at Skin Cancer’s Ask a Skin Cancer Nurse program.

Krista M. Rubin, RN, MS, FNP-BC, is Chair of the Melanoma Nursing Initiative (MNI), a nurse practitioner in the Center for Melanoma at Massachusetts General Hospital, and AIM at Skin Cancer’s Ask a Skin Cancer Nurse program. She has been involved in the care of patients with melanoma and nonmelanoma skin cancers for the past 20+ years. She has extensive expertise in the diagnosis, management and treatment of patients with both early and late-stage skin cancers. She lectures internationally and has authored numerous articles on the topic of skin cancer. Her area of expertise includes immunotherapies, targeted therapies, and symptom management. Krista is a passionate advocate of sun safety and prevention efforts.

In her clinical practice, Krista provides care to patients receiving immunotherapies, targeted therapies, and various investigational agents with a special interest in recognizing and managing immune-related toxicity.

She has consulted, served on numerous planning committees, and has lectured at local, regional, national, and international conferences. She has authored or co-authored numerous articles in peer-reviewed journals on the various aspects of skin cancer treatment and toxicity management.

Krista currently serves as a panel member for the Society of Immunotherapy in Cancer’s (SITC) Cutaneous Melanoma Immunotherapy Guidelines Committee and Cancer Immunotherapy Guidelines Oversight Committee.